In a phase I and II clinical trials on RNA vaccines, the safety and feasibility of vaccination with autologous dendritic cells transfected with CEA tumor antigen-encoding mRNA were investigated among CRC patients with metastatic liver surgery. This evidence concerns the gene LINC01194 and colorectal carcinoma.